一个可向的OSGIN1 - AMPK - SLC2A3轴控制卵巢癌对铁亡的脆弱性
Mengqi Deng1,2, Fan Tang1,2, Xiangyu Chang1,2
1Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital, 100006, Beijing, China.
NPJ precision oncology
|January 14, 2025
概括
丢失OSGIN1促进卵巢癌的生长和耐药性,通过上调SLC2A3,阻碍铁亡. 用抗体准SLC2A3可增强化疗,提供一种新的卵巢癌治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞应激反应的应激反应
背景情况:
- 尽管化疗取得了进展,但卵巢癌的治疗选择仍然有限.
- 氧化应激诱导生长抑制剂1 (OSGIN1) 是一种瘤抑制基因,涉及到卵巢癌.
- 目前尚不清楚OSGIN1在卵巢癌中对铁亡调节的作用.
研究的目的:
- 研究OSGIN1在卵巢癌细胞中的作用和调控机制.
- 阐明OSGIN1如何影响卵巢癌中的铁亡.
主要方法:
- 在卵巢癌细胞中研究了OSGIN1基因功能.
- 分析了通过ATM激活AMPK信号通路的情况.
- 检查了SLC2A3.3的表达.
- 在患者衍生异种移植模型中利用SLC2A3中和抗体.
主要成果:
- 失去OSGIN1加速了卵巢癌的生长,并诱导了对铁亡的抗性.
- OSGIN1缺陷激活了ATM/AMPK信号,从而调节了SLC2A3.3.
- 上调的SLC2A3保护了卵巢癌细胞免受铁亡.
- 一种SLC2A3中和抗体在体内增强了索拉费尼布的诱导铁和抗癌作用.
结论:
- 通过ATM/AMPK/SLC2A3通路,OSGIN1的丧失促进了卵巢癌的进展和铁亡抵抗.
- 向SLC2A3代表了一种有前途的治疗策略,以增强基于铁灭的卵巢癌治疗.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.6K
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.3K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
